Sabadell, Spain

Victor Sanchez-clares

This inventor holds 1 USPTO granted patent. Top assignees: Esteve Pharmaceuticals, S.a., Universität Autonoma De Barcelona. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor Sanchez-clares. Retrieved from https://idiyas.com/inventor/victor-sanchez-clares

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Victor Sanchez-Clares: Innovator in Mucopolysaccharidosis Research

Introduction

Victor Sanchez-Clares is a notable inventor based in Sabadell, Spain. He has made significant contributions to the field of medical research, particularly in the study of mucopolysaccharidosis type IVA, also known as Morquio A syndrome. His work has implications for understanding and treating this rare genetic disorder.

Latest Patents

Victor Sanchez-Clares holds a patent for an "Animal model of mucopolysaccharidoses type IVA." This invention provides a new animal model for mucopolysaccharidosis type IVA and outlines methods for generating this model and its various uses. The patent represents a crucial step forward in the research and potential treatment of this condition.

Career Highlights

Throughout his career, Victor has worked with esteemed organizations, including Esteve Pharmaceuticals, S.A. and Universitat Autònoma de Barcelona. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Victor has collaborated with notable colleagues, including Maria-Fátima Bosch-Tubert and Joan Bertolín-Gálvez. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Victor Sanchez-Clares is a dedicated inventor whose work in developing an animal model for mucopolysaccharidosis type IVA has the potential to advance medical research and treatment options for this condition. His contributions reflect a commitment to innovation in the field of genetics and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…